ファーマフーズ（2929） – (Delayed) Summary of Consolidated Financial Results for the Nine Months Ended April 30, 2022 (Based on Japanese GAAP)

Translation Notice: This document is an excerpt translation of the original Japanese document and is only for reference purposes. In the event of any discrepancy between this translated document and the original Japanese document, the latter shall prevail. Summary of Consolidated Financial Results for the Nine Months Ended April 30, 2022 (Based on Japanese GAAP) Pharma Foods International Co.,Ltd. Company name: Stock exchange listing: Tokyo Stock code: Representative: 2929 President URL https://www.pharmafoods.co.jp Mujo Kim Inquiries: General Manager of Administration Department Atsushi Yamatsu TEL 075-394-8600 June 3, 2022Scheduled date to file Quarterly Securities Report: Scheduled date to commence dividend payments: June 14, 2022 – Preparation of supplementary material on quarterly financial results: Yes No Holding of quarterly financial results meeting: 1. Consolidated financial results for the nine months ended April 30, 2022 (from August 1, 2021 to April 30, 2022) (1) Consolidated operating results (cumulative) Net sales Operating profit Percentages indicate year-on-year changesProfit attributable to owners of parent Ordinary profit Nine months ended April 30, 2022 Nine months ended April 30, 2021 Millions of yen 30.5 44,050 33,748 203.7 % Millions of yen 931 2,633 % Millions of yen 1,076 2,716 (64.6)– % Millions of yen (284) 1,553 (60.4)– % – – (Amounts less than one million yen are rounded down)Nine months ended April 30, 2022 Nine months ended April 30, 2021 (2) Consolidated financial position As of April 30, 2022 As of July 31, 2021 2. Cash dividends Earnings per share Diluted earnings per share Yen (9.80)53.49 Yen – 53.46 Total assets Net assets Equity ratio Millions of yen 30,273 20,944 Millions of yen 7,097 8,465 % 23.4 40.4 1st quarter-end 2nd quarter-end 3rd quarter-end Fiscal year-end Total Annual dividends per share Year ended July 31, 2021 Year ending July 31, 2022 Year ending July 31, 2022 (Forecast) Yen – – Yen 5.00 10.00 Yen – – Yen 20.00 10.00 Yen 25.00 20.00 3. Forecast of consolidated financial results for the year ending July 31, 2022 (from August 1, 2021 to July 31, 2022) Net sales Operating profit Ordinary profit Percentages indicate year-on-year changesProfit attributable to owners of parent Earnings per share Full year Millions of yen 60,900 % Millions of yen 3 30.3 % Millions of yen 147 (99.9)% Millions of yen (1,500) (97.5)% – Yen (51.71) 14. Notes (1) Changes in significant subsidiaries during the nine months ended April 30, 2022 (changes in specified subsidiaries resulting in the change in scope of consolidation): (2) Application of special accounting methods for preparing quarterly consolidated financial statements: No (3) Changes in accounting policies, changes in accounting estimates, and restatement of prior period financial statements Changes in accounting policies due to revisions to accounting standards and other regulations: Changes in accounting policies due to other reasons: Changes in accounting estimates: Restatement of prior period financial statements: (4) Number of issued shares (common shares) Total number of issued shares at the end of the period (including treasury shares) No Yes No No No As of April 30, 2022 29,073,800 shares As of July 31, 2021 29,062,100 shares Number of treasury shares at the end of the period As of April 30, 2022 50,053 shares As of July 31, 2021 – shares Average number of shares during the period (cumulative from the beginning of the fiscal year) Nine months ended April 30, 2022 29,002,044 shares Nine months ended April 30, 2021 29,051,563 shares 2 As of July 31, 2021 As of April 30, 2022 (Millions of yen) 9,794 4,920 – 2,659 54 35 473 (3) 17,933 1,808 879 4 178 726 20 – 140 45 185 335 680 (0) 1,016 3,010 20,944 9,545 5,946 567 4,832 472 628 1,173 (2) 23,165 2,526 393 176 1,491 33 76 4,700 222 36 259 1,380 768 (0) 2,149 7,108 30,273 Quarterly consolidated financial statements Consolidated balance sheets Assets Current assets Cash and deposits Notes and accounts receivable – trade Electronically recorded monetary claims – operating Merchandise and finished goods Work in process Raw materials and supplies Other Allowance for doubtful accounts Total current assets Non-current assets Property, plant and equipment Buildings and structures, net Machinery, equipment and vehicles, net Tools, furniture and fixtures, net Land Leased assets, net Construction in progress Total property, plant and equipment Intangible assets Goodwill Other Total intangible assets Investments and other assets Investment securities Other Allowance for doubtful accounts Total investments and other assets Total non-current assets Total assets 3 As of July 31, 2021 As of April 30, 2022 (Millions of yen) Liabilities Current liabilities Notes and accounts payable – trade Short-term borrowings Current portion of long-term borrowings Accounts payable – other Income taxes payable Provision for bonuses Other Total current liabilities Non-current liabilities Long-term borrowings Retirement benefit liability Other Total non-current liabilities Total liabilities Net assets Shareholders’ equity Share capital Capital surplus Retained earnings Treasury shares Total shareholders’ equity Accumulated other comprehensive income Valuation difference on available-for-sale securities Total accumulated other comprehensive income Share acquisition rights Total net assets Total liabilities and net assets 846 2,500 939 3,283 2,000 3 1,404 10,978 1,458 16 24 1,499 12,478 2,038 1,817 4,599 8,455 – 8 8 1 8,465 20,944 1,169 13,000 745 5,677 105 21,674 168 808 913 435 152 1,501 23,176 2,042 1,820 3,390 (138) 7,114 (17) (17) 0 7,097 30,273 4Consolidated statements of income (cumulative) and consolidated statements of comprehensive income (cumulative) Consolidated statements of income (cumulative) (Millions of yen) Nine months ended Nine months ended April 30, 2021 April 30, 2022 33,748 5,062 28,685 354 19,365 1,973 32 4,327 26,052 2,633 2 0 22 34 9 12 15 97 9 5 0 – – 0 0 14 2,716 2,715 1,161 1,553 1,553 44,050 8,828 35,222 475 26,158 2,465 34 5,156 34,290 931 175 1 24 29 74 12 12 21 18 12 0 30 82 82 0 0 1,076 1,158 1,442 (284) (284) Share of profit of entities accounted for using equity method Outsourcing service income Total selling, general and administrative expenses Net sales Cost of sales Gross profit Selling, general and administrative expenses Research and development expenses Advertising expenses Commission expenses Amortization of goodwill Other Operating profit Non-operating income Interest income Dividend income Foreign exchange gains Subsidy income Other Total non-operating income Non-operating expenses Interest expenses Commission expenses Other Total non-operating expenses Ordinary profit Extraordinary income Gain on bargain purchase Total extraordinary income Extraordinary losses Total extraordinary losses Profit before income taxes Income taxes Profit (loss) Loss on retirement of non-current assets Profit (loss) attributable to owners of parent 5Consolidated statements of comprehensive income (cumulative) (Millions of yen) Nine months ended Nine months ended April 30, 2021 April 30, 2022 Profit (loss) Other comprehensive income Valuation difference on available-for-sale securities Deferred gains or losses on hedges Total other comprehensive income Comprehensive income Comprehensive income attributable to Comprehensive income attributable to owners of parent 1,553 (24) 0 (24) 1,529 1,529 (284) (26) – (26) (310) (310) 6